I value being part of the largest and fastest growing user community of its kind in the world

Instem Client

Galderma to Implement Provantis 7

April 2005

Instem announced today that Galderma has signed a Provantis 7 license agreement for its new state-of-the-art R&D facility in Sophia Antipolis, South East France.

Galderma, who specialize in developing and marketing treatments for major skin conditions, has purchased an extensive suite of Provantis modules including Labeling, Tables & Statistics and Protocol & Report Assembly.

Galderma chose Provantis 7 following a series of comprehensive on-site demonstrations and evaluation visits towards the end of 2004. Many of Galderma's studies are extremely specialized and the company has chosen Provantis as their ideal solution to handle their complex study workload.

Franck Chuzel, Head of Safety at Galderma R&D, comments " Following a detailed competitive evaluation we selected Provantis 7 because of the complete breadth and depth of the integrated solution. We were also extremely impressed with Instem's extensive Support and Services capability, which was critical in our decision criteria."

Gregor Grant, Instem's VP Sales, states " We are delighted to welcome Galderma as one of our most recent customers. Following recent success at Pierre Fabre, Galderma is yet another French customer to select Provantis to carry out their studies."

About Instem

Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products.

Established in 1969, Instem has offices in the United States and Europe with its solutions supported in thirteen countries. Instem serves large multi-national corporations and smaller organizations in overcoming the challenges of managing information and provides solutions that help them further their missions while creating a competitive advantage. For more information on Instem and its solutions, please visit www.instem-lss.com or contact them by email at info@instem-lss.com.

About Galderma

Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal. Galderma is unique in the pharmaceutical industry in that it focuses purely on the area of dermatology. The company channels its resources into developing quality products to meet the needs of dermatologists and their patients.

Press Contact:

Gary E. Mitchell, VP Global Marketing, Instem US HQ
Tel: (610) 941-0990
Email: gary.mitchell@instem-lss.com

All trademarks used are properties of their respective owners.